Danaher recently announced that the group will establish an independent company, ENVISTA HOLDINGS CORPORATION (referred to as Envista), and will make an initial public offering in the second half of 2019.

Envista will be comprised of Danehe Dental's Nobel Biocare Systems, KaVo Kerr and Ormco. These companies are dominant in dental implants, orthodontics, dental equipment and consumables, including Nobel Biocare, KaVo, Kerr, i-CAT, Dexis, Metrex, Pelton & Crane, Ormco, Implant Direct and Orascoptic.Envista will be led by Amir Aghdaei, who will become President and CEO. Mr. Aghdaei is currently the executive officer of the Danaher Group and is responsible for the dental field.

Danaher announced the independence of the dental business in July last year. Mr. Aghdaei said: "Envista's name is a combination of two Latin roots: 'en', the prefix means 'vista', meaning a point of view. This means that we can achieve unlimited possibilities through collaboration, the Envista brand also reflecting the forward-looking energy of the company culture."

Aghdaei continues, “Envista's culture will be built on four core values: better choices, better results, trust-based relationships, action innovation and continuous improvement as a competitive advantage.Danaher helped us shape these values and laid a solid foundation for our business. Envista will build on the Danaher DBS system and adhere to a common operating model. ”

Envista will employ 12,000 people worldwide. The company is expected to be listed on the New York Stock Exchange under the symbol NVST.